Finance

Lists
Why is GH down 9,73%?
Dive Deeper
GH:BMV
Guardant Health Inc
MXN 2 784,00
-9,73%
(-300,18) 1D
3 Aug., 10:36:06 GMT-6  ·   MXN
All symbols
SymbolPriceChange% Change
Generating top insights for GH...
Mkt. cap
21,75 mjd
Avg. vol.
0,00
Volume
0,00
52-wk high
MXN 3 395,10
52-wk low
MXN 1 138,30
No. of employees
2 k
Mkt. cap
21,75 mjd
Avg. vol.
0,00
Volume
0,00
52-wk high
MXN 3 395,10
52-wk low
MXN 1 138,30
No. of employees
2 k
News stories
From web sources and news partners
Profile
Guardant Health, Inc. is an American biotechnology company based in Palo Alto, California. Co-founders Helmy Eltoukhy and AmirAli Talasaz serve as co-chief executive officers. Wikipedia
About Guardant Health Inc
CEOHelmy Eltoukhy | AmirAli Talasaz
Employees2,5 k
Founded2012
HeadquartersPalo Alto, Kalifornië, Verenigde State van Amerika
SectorHealth care provider
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
Sep. 2025
Des. 2025
Mrt. 2026
Jun. 2026
Revenue
265,20 m
281,27 m
301,66 m
334,98 m
Cost of goods sold
93,59 m
99,49 m
104,92 m
115,95 m
Cost of revenue
93,59 m
99,49 m
104,92 m
115,95 m
Research and development expenses
89,96 m
98,26 m
91,04 m
96,53 m
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
180,53 m
204,20 m
227,06 m
250,61 m
Operating expense
270,48 m
302,46 m
318,10 m
347,15 m
Total operating expenses
364,07 m
401,96 m
423,02 m
463,10 m
Operating income
-98,87 m
-120,69 m
-121,35 m
-128,12 m
Other non operating income
-48,00 k
-4,69 m
1,55 m
308,00 k
EBT including unusual items
-92,59 m
-130,22 m
-111,70 m
-119,96 m
EBT excluding unusual items
-92,47 m
-116,52 m
-111,70 m
-118,96 m
Income tax expense
136,00 k
-1,73 m
372,00 k
185,00 k
Effective tax rate
-0,15%
1,33%
-0,33%
-0,15%
Other operating expenses
-
-
-
-
Net income
-92,72 m
-128,49 m
-112,08 m
-120,14 m
Net profit margin
-34,96%
-45,68%
-37,15%
-35,87%
Earnings per share
-0,39
-0,50
-0,45
-0,42
Interest and investment income
7,39 m
10,03 m
11,15 m
10,20 m
Interest expense
-943,00 k
-1,18 m
-3,05 m
-1,35 m
Net interest expenses
6,45 m
8,85 m
8,10 m
8,85 m
Depreciation and amortization charges
-
-
-
-
EBITDA
-89,47 m
-110,64 m
-111,91 m
-118,56 m
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
Google-programme